Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: The prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validation

Fig. 3

Correlation of SRF expression in bone metastases and survival: Tissues of docetaxel resistant prostate cancer bone metastases obtained at Rapid Autopsy were stained for SRF (N = 23). Time from (a) Prostate Cancer Diagnosis, (b) Castration Resistance and (c) Bone Metastases to death [Survival (Years)] was correlated with positivity of SRF in stained tissue samples. Correlation curves (i) and Kaplan-Meier curves (ii) at each of these time points respectively demonstrate the strong statistically significant negative correlation between nuclear expressivity of SRF and survival outcomes

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us